Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,588,825
+$10,475,585 QoQ
Shares Held
506,158
+512.4% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. TNGX ranks #46 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in TNGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,588,825 | 506,158 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $113,240 | 82,657 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $34,601 | 11,198 | Shares | Defined | 2025-02-14 | |
| 2023-09-30 | $143,170 | 12,715 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $170,179 | 51,259 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $207,153 | 52,444 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $203,072 | 28,010 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $101,360 | 28,000 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||